Gilead Sciences Eulerpool Nieuws

Gilead Sciences Eulerpool News

Gilead Sciences Aandeel Nieuws

Gilead Sciences wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Gilead Sciences nieuwsberichten verzamelen we hier.

• 4 oktober ·

  Benzinga
  Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
• 3 oktober ·

  Yahoo
  Gilead signs agreements to facilitate access to HIV prevention drug
• 2 oktober ·

  Yahoo
  Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
• 2 oktober ·

  Yahoo
  Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
• 2 oktober ·

  Thefly.com
  Dr. Reddy's signs licensing agreement with Gilead for lenacapavir in India
• 2 oktober ·

  Thefly.com
  Hetero signs licensing agreement with Gilead expanding access to Lenacapavir
• 2 oktober ·

  Seeking Alpha
  Gilead signs deals with six drugmakers for generic lenacapavir
• 2 oktober ·

  Thefly.com
  Gilead in royalty-free generic manufacturing deals for lenacapavir for HIV
• 1 oktober ·

  SeekingAlpha
  Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It
• 28 september ·

  Seeking Alpha
  Here are the Medicare Part D drugs expected to face 2025 price negotiations